PRL2 Inhibition Elevates PTEN Protein and Ameliorates Progression of Acute Myeloid Leukemia

APTEN-knockdown AML animal model was generated to assess the impact of conditional phosphatases of regenerating liver 2 (PRL2) inhibition on the level of PTEN protein and the development and progression of AML.